We started off the 2016 winter-spring season strong, with 10 webinars to date! We hope you have been enjoying this increase in educational webinars as a member benefit.
As a reminder, we have even more coming up this spring-summer:
May 18, 2016 at 11AM Eastern time
Title: Current Perspectives and Approaches for Characterizing Auditory Liability During Drug Development
Presenter: Matthew M. Abernathy, PhD, Research Scientist, Eli Lilly and Company
May 26, 2016 at 11AM Eastern time
Title: Overview of translational biomarkers of cardiovascular injury and dysfunction
Presenter: Brian Berridge, DVM, PhD, DACVP, Glaxosmithkline
June 2, 2016 at 11AM Eastern time
Title 1: Exciting Challenges in the Preclinical Abuse Liability Testing of Novel CNS-Active Drug Candidates
Presenter: Greet Teuns, DVM, PhD, MSc, Janssen Pharmaceutical Research & Development
Title 2: Progress Relative to CiPA Activities: A Regulatory Perspective
Presenter: David Strauss, MD, PhD, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
June 9, 2016 at 11AM Eastern time
Title: The Current Clinical Approach to Assessing Human Proarrhythmia Risk and Future Directions
Presenter: Philip Sager, MD, FACC, FAHA, FHRS, Consulting Professor of Medicine Stanford University School of Medicine Chair, Scientific Programs Committee, Cardiac Safety Research Consortium
If you are not presently a Member, Join Us to gain access to these Webinars! One of the Safety Pharmacology Society’s (SPS) Membership benefits include the ability to access our educational webinars live, as well as access to the recorded content to reference/view at your leisure.
We hope to see you at an upcoming event.